4.02
-0.34 (-7.8%)
-0.34 (-7.8%)
Upgrade to Real-Time
Regular Market
| Volume | 835,264 |
|
|||||
| News | (1) | ||||||
| Day High | 4.38 | Low High |
|||||
| Day Low | 4.00 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NRX Pharmaceuticals Inc | NRXP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.34 | -7.8% | 4.02 | 15:16:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.38 | 4.00 | 4.38 | 4.36 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,196 | 835,264 | $ 4.15 | $ 3,469,183 | - | 4.00 - 26.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:16:57 | 3 | $ 4.015 | USD |
Period:
Draw Mode:
NRX Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 236.42M | 58.81M | 58.65M | $ - | $ - | -7.35 | -0.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -942.90k | 0.30% |
NRX Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NRXP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.86 | 5.07 | 4.00 | 4.60 | 788,952 | -0.84 | -17.28% |
| 1 Month | 5.21 | 5.655 | 4.00 | 4.91 | 1,451,121 | -1.19 | -22.84% |
| 3 Months | 9.65 | 10.78 | 4.00 | 6.92 | 3,218,004 | -5.63 | -58.34% |
| 6 Months | 12.50 | 26.24 | 4.00 | 12.62 | 4,743,860 | -8.48 | -67.84% |
| 1 Year | 23.01 | 26.24 | 4.00 | 12.64 | 3,731,077 | -18.99 | -82.53% |
| 3 Years | 23.01 | 26.24 | 4.00 | 12.64 | 3,731,077 | -18.99 | -82.53% |
| 5 Years | 23.01 | 26.24 | 4.00 | 12.64 | 3,731,077 | -18.99 | -82.53% |
NRX Pharmaceuticals Description
| NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. |